Last update 21 Nov 2024
STSA-1002
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism C5a inhibitors(complement C5a inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
7
Clinical Trials associated with STSA-1002随机、双盲、安慰剂对照评价STSA-1002注射液在急性呼吸窘迫综合征患者中的安全性及初步疗效的Ib/II期临床研究
[Translation] A randomized, double-blind, placebo-controlled Phase Ib/II clinical study to evaluate the safety and preliminary efficacy of STSA-1002 injection in patients with acute respiratory distress syndrome
Phase Ib/II Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Initial Efficacy of STSA-1002 Injection in Patients with Acute Respiratory Distress Syndrome
An Open-label, Single-ascending Dose, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of STSA-1002 Subcutaneous Injection in Healthy Subjects
100 Clinical Results associated with STSA-1002
Login to view more data
100 Translational Medicine associated with STSA-1002
Login to view more data
100 Patents (Medical) associated with STSA-1002
Login to view more data
100 Deals associated with STSA-1002
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Respiratory Distress Syndrome, Adult | Phase 2 | CN | 09 Dec 2023 | |
| COVID-19 | Phase 2 | CN | 22 Aug 2022 | |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Phase 1 | US | 31 Jan 2023 | |
| COVID-19 | Preclinical | US | 22 Aug 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free